Dihydroartemisinin Synergistically Promotes the Antileukemic Activity of Venetoclax By Downregulating Mcl-1 in Acute Myeloid Leukemia Cells

被引：0
|
作者：
Zhuang, Haihui [1 ]
Chen, Yao [1 ]
Li, Fenglin [1 ]
Jin, Jie [2 ]
Lu, Ying [3 ]
机构：
[1] Ningbo Univ, Dept Hematol, Affiliated Peoples Hosp, Ningbo, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[3] Yinzhou Peoples Hosp, Dept Hematol, Ningbo, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
    Hyunsoo Cho
    Ji Eun Jang
    Ju-In Eom
    Hoi-Kyung Jeung
    Haerim Chung
    Jin Seok Kim
    June-Won Cheong
    Yoo Hong Min
    Experimental Hematology & Oncology, 10
  • [2] Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
    Cho, Hyunsoo
    Jang, Ji Eun
    Eom, Ju-In
    Jeung, Hoi-Kyung
    Chung, Haerim
    Kim, Jin Seok
    Cheong, June-Won
    Min, Yoo Hong
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [3] Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
    Zhou, Fang-jiao
    Zeng, Chen-xing
    Kuang, Wei
    Cheng, Cong
    Liu, Hong-cai
    Yan, Xue-ying
    Chen, Xiao-ping
    Zhou, Gan
    Cao, Shan
    JOURNAL OF CANCER, 2021, 12 (22): : 6727 - 6739
  • [4] Wnt/β-Catenin Inhibitor Combined with Venetoclax Synergistically Induce Apoptosis in Acute Myeloid Leukemia By Increasing the Degradation of MCL-1 Protein
    Pan, Mengya
    Sun, Menghua
    Zhou, Junjie
    Jiao, Changqing
    Chen, Enbo
    Wu, Zhonghui
    Ma, Xiaoyu
    Liu, Xiaoying
    Ge, Jian
    BLOOD, 2024, 144 : 5779 - 5780
  • [5] Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia
    Wu, Shuangshuang
    Edwards, Holly
    Wang, Deying
    Liu, Shuang
    Qiao, Xinan
    Carter, Jenna
    Wang, Yue
    Taub, Jeffrey W.
    Wang, Guan
    Ge, Yubin
    CELLS, 2022, 11 (17)
  • [6] Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes
    Jiang, Jiqian
    Wang, Yan
    Liu, Dan
    Wang, Xiaoyu
    Zhu, Yingqiao
    Tong, Juan
    Chen, Erling
    Xue, Lei
    Zhao, Na
    Liang, Tingting
    Zheng, Changcheng
    IMMUNOTARGETS AND THERAPY, 2023, 12 : 135 - 147
  • [7] ACID CERAMIDASE PROMOTES ACUTE MYELOID LEUKEMIA SURVIVAL THROUGH MCL-1 UPREGULATION
    Tan, S.
    Liu, X.
    Fox, T.
    Barth, B.
    Awwad, A.
    Fabrias, G.
    Feith, D.
    Loughran, T.
    HAEMATOLOGICA, 2013, 98 : 14 - 14
  • [8] Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
    Hu, Xiaoyan
    Li, Lin
    Nkwocha, Jewel
    Kmieciak, Maciej
    Shang, Shengzhe
    Cowart, L. Ashley
    Yue, Yang
    Horimoto, Katsuhisa
    Hawkridge, Adam
    Rijal, Arjun
    Mauro, Adolfo G.
    Salloum, Fadi N.
    Hazlehurst, Lori
    Sdrimas, Konstantinos
    Moore, Zackary
    Zhou, Liang
    Ginder, Gordon D.
    Grant, Steven
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [9] Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
    Teh, T-C
    Nguyen, N-Y
    Moujalled, D. M.
    Segal, D.
    Pomilio, G.
    Rijal, S.
    Jabbour, A.
    Cummins, K.
    Lackovic, K.
    Blombery, P.
    Thompson, E.
    Ekert, P. G.
    Lessene, G.
    Glaser, S. P.
    Huang, D. C. S.
    Roberts, A. W.
    Guthridge, M. A.
    Wei, A. H.
    LEUKEMIA, 2018, 32 (02) : 303 - 312
  • [10] Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression
    Doi, Kenichiro
    Liu, Qiang
    Gowda, Krishne
    Barth, Brian M.
    Claxton, David
    Amin, Shantu
    Loughran, Thomas P., Jr.
    Wang, Hong-Gang
    CANCER BIOLOGY & THERAPY, 2014, 15 (08) : 1077 - 1086
12345